Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro

Oncogene

Volumn 15, Issue 1, 1997, Pages 107-115

  Zhou, Qun ^a   Stetler Stevenson, Maryalice ^a   Steeg, Patricia S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

9 cis retinoic acid; All trans retinoic acid; Breast cancer; Cdk2; Cdk4; Cyclin D

Indexed keywords

ALITRETINOIN; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLINE; RETINOIC ACID; RETINOID; TAMOXIFEN;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

MINK CELL FOCUS-FORMING VIRUS; MUS MUSCULUS;

EID: 0030787048     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201142     Document Type: Article

References (53)

1. Anzano MA, Byers SW, Smith JM, Peer CW, Mullen LT, Brown CC, Roberts AB and Sporn MB. (1994). Cancer Res., 54, 4614-4617.
2. Asano K, Sakamoto H, Sasaki H and Ochiya T. (1995). Biochem. Biophys. Res. Commun., 217, 1169-1176.
3. Bartkova J, Zemanova M and Bartek J. (1996). Int. J. Cancer, 65, 323-327.
4. Buckley M, Sweeney K, Hamilton J, Sini R, Manning D, Nicholson R, deFazio A, Watts C, Musgrove E and Sutherland D, (1993). Oncogene, 8, 2127-2133.
5. Costa A, Formelli F, Chiesa F, Decensi A, Palo GD and Veronesi U. (1994). Cancer Res. 7 Suppl, 2032s-2037s.
6. Courjal F, Louason G, Speisere P, Katsaros D, Zellinger R and Thiellet C. (1996). Int. J. Cancer, 69, 247-253.
7. Dhingra K. (1995). J. Cell. Biochem. Suppl., 23, 19-24.
8. DuPont W and Page D. (1985). New Engl. J. Med., 312, 146-151.
9. Dutta A, Chandra R, Leiter L and Lester S. (1995). Proc. Natl. Acad. Sci. USA, 92, 5386-5390.
10. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato JY and Livingston DM. (1993). Cell, 73, 487-497.
11. Fontana JA. (1987). Exptl. Cell. Biol., 55, 136-144.
12. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D and Peters G. (1994). Cancer Res., 54, 1812-1817.
13. Glick AB, Flanders KC, Danielpour D, Yuspa SH and Sporn MB. (1989). Cell Regulation, 1, 87-97.
14. Gorospe M, Liu Y, Xu Q, Chrest FJ and Holbrook NJ. (1996). Mol. Cell. Biol., 14, 762-770.
15. Han EK-H, Sgambato A, Jiang W, Zhang Y-J, Santella R, Doki Y, Cacace A, Schieren I and Weinstein I. (1995). Oncogene, 10, 953-961.
16. Hinds PW, Dowdy SF, Eaton EN, Arnold A and Weinberg RA. (1994). Proc. Natl. Acad. Sci. USA, 91, 709-713.
17. Hunter T and Pines J. (1994). Cell, 79, 573- 582.
18. Jeoung D, Tang B and Sonnenberg M. (1995). J. Biol. Chem., 270, 18367-18373.
19. Jiang W, Kahn SM, Zhou P, Zhang Y, Cacace AM, Infante AS, Doi S, Santella RM and Weinstein IB. (1993). Oncogene, 8, 3447-3457.
20. Keyomarsi K, D Conte J, Toyofuku W and Fox M. (1995). Oncogene, 11, 941-950.
21. Keyomarso K and Pardee A. (1993). Proc. Natl. Acad. Sci. USA, 90, 1112-1116.
22. Lama G, Angelucci C, Recchia F and Sica G. (1996). Cancer Lett., 100, 181-189.
23. Lotan R. (1996). FASEB J., 10, 1031-1039.
24. Love R. (1994). Monogr. Natl. Cancer Inst., 1994, 61-65.
25. Lovec H, Sewing A, Lucibello FC, Muller R and Moroy T, (1994). Oncogene, 9, 323-326.
26. Man T. (1994). Leukemia, 8, 1785-1790.
27. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ and Kato JY. (1994). Mol. Cell. Biol., 14, 2066-2076.
28. Michalides R, Hageman P, Tinteren HV, Houben L, Wientjens E, Klopmaker R and Peterse J. (1996). Br. J. Cancer, 73, 728-734.
29. Musgrove E, Lee C, Buckley M and Sutherland R. (1994). Proc. Natl. Acad. Sci. USA. 91, 8022-8026.
30. Noguchi M, Rose D and Miyazaki I. (1996). Oncology, 53, 175-181.
31. Pagano M, Theodoras AM, Tam SW and Draetta GF. (1994). Genes Devt., 8, 1627-1639.
32. Page D and DuPont W. (1993). Breast Cancer Res. Trt., 28, 157-166.
33. Rubin M, Fenig E, Rosenauer A, Menendez-Botet C, Achkar C, Bentel JM, Yahalom J, Mendelsohn J and Miller WH. (1994). Cancer Res., 54, 6549-6556.
34. Savatier P, Lapillonne H, Grunsven LAV, Rudkin BB and Samarut J. (1995). Oncogene, 12, 309-322.
35. Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B and Fontana JA. (1995). Oncogene, 11, 493 504.
36. Sherr CJ. (1994). Cell, 79, 551-555.
37. Sicinski P, Donaher J, Parker S, Li T, Fazeli A, Gardner H, Haslam S, Bronson R, Elledge S and Weinberg R. (1995). Cell, 82, 621-630.
38. Simpson JF, Quan DE, O'Malley F, Odom-Maryon T and Clarke PE. Am. J. Pathol. In press.
39. Sporn MB and Roberts AB. (1983). Cancer Res., 43, 3034-3040.
40. Strickland S, Smith KK and Marotti KR. (1980). Cell, 21, 347-355.
41. Tam SW, Theodoras AM, Shay JW, Draetta GF and Pagano M. (1994). Oncogene, 9, 2663-2674.
42. Wang T, Cardiff R, Zukerberg L, Lees E, Arnold A and Schmidt E. (1994). Nature, 369, 669-671.
43. Watts C, Brady A, Sarcevic B, deFazio A, Musgrove E and Sutherland R. (1995). Mol. Endocrinol., 9, 1804-1813.
44. Watts C, Sweeney K, Warlters A, Musgrove E and Sutherland R. (1994). Breast Cancer Res. Treat., 31, 95 105.
45. Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL and Steeg PS. (1995). Nature Medicine. 1, 1257-1260.
46. Wersto RP and Stetler-Stevenson M. (1995). Cytometry, 20, 43-52.
47. Wetherall NT and Taylor CM. (1986). European J. Clin. Oncol., 22, 53-59.
48. Xiong Y, Zhang H and Beach D. (1992). Cell, 71, 505-514.
49. Zhang S-Y, Caamano J, Cooper F, Guo X and Klein-Szanto A. (1994). Am. J. Clin. Pathol., 102, 695-698.
50. Zhao ZM, Sheikh MS, Rishi AK, Dawson MI, Li XS, Wilber JF, Feng P and Fontana JA. (1995). Expt. Cell. Res., 219, 555-561.
51. Zhou P, Jiang W, Weghorst CM and Weinstein IB. (1996). Cancer Res., 56, 36-39.
52. Zuckerberg L, Yang W, Gadd M, Thor A, Koerner F, Schmidt E and Arnold A. (1995). Mod. Pathol., 8, 560-567.
53. Zwijsen RM, Klompmaker R, Wientjens EB, Kristel PM, Burg BVD and Michalides RJ. (1996). Mol. Cell. Biol., 16, 2554-2560.